Skip to content

Genotyping 2 SNPs in Chinese Breast Cancers

Study of Two Single Nucleotide Polymorphisms in Chinese Breast Cancers

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02886845
Enrollment
2000
Registered
2016-09-01
Start date
2016-08-31
Completion date
2023-06-30
Last updated
2022-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rs185670819 and rs183489969

Keywords

SNP,Breast Neoplasms

Brief summary

The purpose of this study is to determine the frequency of two Single Nucleotide Polymorphisms (SNPs) by sanger-sequencing in Breast Cancers and healthy controls .

Detailed description

Since the 1990s breast cancers incidence of china has increased more than twice as fast as global rates. Chinese patients are responsible for 12.2% of all newly diagnosed breast cancers and 9.6% of all deaths to world breast cancers. Breast cancer is now the second frequently diagnosed cancer and is the leading cause of cancer-related death in Chinese women. Two of the most prevalent breast cancer susceptibility genes are BRCA1and BRCA2. However,because of population based Genetic heterogeneity, the frequency of BRCA1/BRCA2 mutation is not as high in Caucasian population as in China. Anyway, the mean age at diagnosis of breast cancer in China is almost 10 years younger and more cases are diagnosed before 40 than those in Caucasians. Therefore, it is believed that there are certain specific susceptibility loci in Chinese breast cancers. In preliminary experiments, investigators found two germline mutations may associate with Chinese breast cancers. The purpose of the study is to determine the frequency of two germline mutations by sanger-sequencing in a larger sample of Chinese breast cancers

Interventions

GENETICrs183489969,rs185670819

compare the frequency of two germline mutations in breast cancers and controls

Sponsors

Song Hongping
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Woman aged superior to 18 years old Inform consent signed Woman without breast cancer and family history of cancer

Exclusion criteria

* No inform consent signed Patient under guardianship, curatorship Psychosocial disorder

Design outcomes

Primary

MeasureTime frame
Genotyping of 2 SNPs ( rs185670819 and rs183489969) in Chinese breast cancer patients and age-matched healthy control women .January of 2019

Secondary

MeasureTime frame
Both of the 2 SNPs' minor allele frequency or affected ratio shows statistically significant differences between case and control groupsJune of 2019

Countries

China

Contacts

Primary Contacthongping song, PhD
Songhp@fmmu.edu.cn+86-29-84771663

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026